Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Cannabis Science Inc    

 SummaryNewsCompany 
Company
Cannabis Science, Inc. develops cannabis pharmaceutical products.The company works on phytocannabinoid science targeting critical illnesses and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.Cannabis Science was founded by... 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on CANNABIS SCIENCE INC
09/22 CANNABIS SCIENCE : 'Nanoparticle Drones to Target Lung Cancer with Radiosensitiz..
09/20 CANNABIS SCIENCE : "Nanoparticle Drones to Target Lung Cancer with Radiosensitiz..
09/19 CANNABIS SCIENCE : "Nanoparticle Drones to Target Lung Cancer with Radiosensitiz..
09/18 CANNABIS SCIENCE : Announces Publication of Initial Research Results Using Nanop..
09/14 CANNABIS SCIENCE : Announces Publication of Initial Research Results Using Nanop..
09/11 CANNABIS SCIENCE : Announces Participation in Major U.S.-Africa Policy Forum in ..
09/08 CANNABIS SCIENCE : and Free Spirit Organics Native American Corporation Report P..
09/05 CANNABIS SCIENCE : and Free Spirit Organics Native American Corporation Report P..
08/30 Revenues for Legal Cannabis Operations Continue To Rise Along with Growing De..
08/28 CANNABIS SCIENCE : and Free Spirit Organics Advance Comprehensive Economic Devel..
More news
Sector news : Bio Therapeutic Drugs
09/20DJSANOFI : Alnylam Report Positive Patisiran Phase III Trial, First-Ever for RNAi ..
09/15 Drug industry on tenterhooks as Maryland price-gouging law nears
09/07 New AstraZeneca, Amgen drug looks strong rival in severe asthma
08/30DJFDA Approves Pioneering Cancer Treatment With $475,000 Price Tag -- Update
08/30DJFDA Approves Pioneering Cancer Treatment With $475,000 Price Tag
More sector news : Bio Therapeutic Drugs
Managers
NameTitle
Raymond C. Dabney President, Chief Executive Officer & Director
Robert Kane Chief Operating Officer & Director
Benjamin C. K. Tam Chief Financial Officer, Secretary & Director
Richard Ogden Chief Scientific Officer
Allen A. Herman Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
CANNABIS SCIENCE INC0
AMGEN28.70%135 544
CELGENE CORPORATION24.61%112 572
GILEAD SCIENCES15.40%108 744
REGENERON PHARMACEUTICALS19.36%46 367
VERTEX PHARMACEUTICALS107.30%38 136